Limits...
Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study.

Koniski ML, Salhi H, Lahlou A, Rashid N, El Hasnaoui A - Int J Chron Obstruct Pulmon Dis (2015)

Bottom Line: The mean BMI was 27.7±5.7 kg/m(2).However, the occurrence of comorbidities such as diabetes and cardiovascular diseases seemed to be significantly associated with obese or morbidly obese status (P=0.02).In the MENA region, the majority of COPD subjects were overweight or obese, and comorbidities such as diabetes or cardiovascular diseases are likely to be associated with COPD when BMI is in the obese or morbidly obese ranges.

View Article: PubMed Central - PubMed

Affiliation: Respiratory Division, Lebanese American University Medical Center - Rizk Hospital, Beirut, Lebanon.

ABSTRACT

Background: Data describing the potential relationship between chronic obstructive pulmonary disease (COPD) and body mass index (BMI) are limited within the Middle East and North Africa (MENA) region.

Objective: To evaluate the distribution of BMI among subjects with COPD in the general population of the MENA region.

Methods: This study was a subanalysis of the BREATHE study, a cross-sectional survey of COPD conducted in the general population of ten countries in the MENA region and Pakistan. The study population consisted of subjects screened for COPD who documented their weight and height. A COPD questionnaire was administered to subjects who screened positively for COPD in order to collect data on patient characteristics, symptom severity, management and burden of disease, comorbidities, and health care resource utilization and data allowing calculation of the BMI. The COPD Assessment Test (CAT) was administered to those screened positively for COPD to collect data on the impact of respiratory symptoms.

Results: Nine hundred and ninety-six subjects with COPD, who completed the detailed COPD questionnaire and documented their weight and height, were included in this analysis. The mean BMI was 27.7±5.7 kg/m(2). The proportion of COPD patients with a BMI ≥25 kg/m(2) is significantly higher than the proportion with a BMI <25 kg/m(2) (64.6% [n=643] vs 35.4% [n=353], respectively; P<0.0001). There were no significant differences between the distribution of BMI, ages, sex, COPD symptoms, exacerbations, CAT scores, COPD-associated health care resource consumption, and GOLD severity groups. However, the occurrence of comorbidities such as diabetes and cardiovascular diseases seemed to be significantly associated with obese or morbidly obese status (P=0.02).

Conclusion: In the MENA region, the majority of COPD subjects were overweight or obese, and comorbidities such as diabetes or cardiovascular diseases are likely to be associated with COPD when BMI is in the obese or morbidly obese ranges.

No MeSH data available.


Related in: MedlinePlus

Distribution of BMI in COPD population according to each participant country. Green bars: underweight (BMI <20 kg/m2); blue bars: normal weight (BMI 20–25 kg/m2); yellow bars: overweight (BMI 25–30 kg/m2); orange bars: obese (BMI 30–35 kg/m2); red bars: morbidly obese (BMI ≥35 kg/m2). The mean BMI (± SD) is provided above the histograms for each country.Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; SD, standard deviation.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4554407&req=5

f3-copd-10-1685: Distribution of BMI in COPD population according to each participant country. Green bars: underweight (BMI <20 kg/m2); blue bars: normal weight (BMI 20–25 kg/m2); yellow bars: overweight (BMI 25–30 kg/m2); orange bars: obese (BMI 30–35 kg/m2); red bars: morbidly obese (BMI ≥35 kg/m2). The mean BMI (± SD) is provided above the histograms for each country.Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; SD, standard deviation.

Mentions: The distribution of BMI in the COPD population by country is presented in Figure 3. Overall, the highest proportion of COPD patients with a BMI ≥30 kg/m2 (obese and morbidly obese categories), was detected in the Gulf countries, and the lowest proportion was detected in the Maghreb countries and Pakistan. The highest proportion of obese subjects with COPD was found in UAE (43.6%; n=7), and the highest proportion of morbidly obese subjects was detected in Saudi Arabia (14.7%; n=21).


Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study.

Koniski ML, Salhi H, Lahlou A, Rashid N, El Hasnaoui A - Int J Chron Obstruct Pulmon Dis (2015)

Distribution of BMI in COPD population according to each participant country. Green bars: underweight (BMI <20 kg/m2); blue bars: normal weight (BMI 20–25 kg/m2); yellow bars: overweight (BMI 25–30 kg/m2); orange bars: obese (BMI 30–35 kg/m2); red bars: morbidly obese (BMI ≥35 kg/m2). The mean BMI (± SD) is provided above the histograms for each country.Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; SD, standard deviation.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4554407&req=5

f3-copd-10-1685: Distribution of BMI in COPD population according to each participant country. Green bars: underweight (BMI <20 kg/m2); blue bars: normal weight (BMI 20–25 kg/m2); yellow bars: overweight (BMI 25–30 kg/m2); orange bars: obese (BMI 30–35 kg/m2); red bars: morbidly obese (BMI ≥35 kg/m2). The mean BMI (± SD) is provided above the histograms for each country.Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; SD, standard deviation.
Mentions: The distribution of BMI in the COPD population by country is presented in Figure 3. Overall, the highest proportion of COPD patients with a BMI ≥30 kg/m2 (obese and morbidly obese categories), was detected in the Gulf countries, and the lowest proportion was detected in the Maghreb countries and Pakistan. The highest proportion of obese subjects with COPD was found in UAE (43.6%; n=7), and the highest proportion of morbidly obese subjects was detected in Saudi Arabia (14.7%; n=21).

Bottom Line: The mean BMI was 27.7±5.7 kg/m(2).However, the occurrence of comorbidities such as diabetes and cardiovascular diseases seemed to be significantly associated with obese or morbidly obese status (P=0.02).In the MENA region, the majority of COPD subjects were overweight or obese, and comorbidities such as diabetes or cardiovascular diseases are likely to be associated with COPD when BMI is in the obese or morbidly obese ranges.

View Article: PubMed Central - PubMed

Affiliation: Respiratory Division, Lebanese American University Medical Center - Rizk Hospital, Beirut, Lebanon.

ABSTRACT

Background: Data describing the potential relationship between chronic obstructive pulmonary disease (COPD) and body mass index (BMI) are limited within the Middle East and North Africa (MENA) region.

Objective: To evaluate the distribution of BMI among subjects with COPD in the general population of the MENA region.

Methods: This study was a subanalysis of the BREATHE study, a cross-sectional survey of COPD conducted in the general population of ten countries in the MENA region and Pakistan. The study population consisted of subjects screened for COPD who documented their weight and height. A COPD questionnaire was administered to subjects who screened positively for COPD in order to collect data on patient characteristics, symptom severity, management and burden of disease, comorbidities, and health care resource utilization and data allowing calculation of the BMI. The COPD Assessment Test (CAT) was administered to those screened positively for COPD to collect data on the impact of respiratory symptoms.

Results: Nine hundred and ninety-six subjects with COPD, who completed the detailed COPD questionnaire and documented their weight and height, were included in this analysis. The mean BMI was 27.7±5.7 kg/m(2). The proportion of COPD patients with a BMI ≥25 kg/m(2) is significantly higher than the proportion with a BMI <25 kg/m(2) (64.6% [n=643] vs 35.4% [n=353], respectively; P<0.0001). There were no significant differences between the distribution of BMI, ages, sex, COPD symptoms, exacerbations, CAT scores, COPD-associated health care resource consumption, and GOLD severity groups. However, the occurrence of comorbidities such as diabetes and cardiovascular diseases seemed to be significantly associated with obese or morbidly obese status (P=0.02).

Conclusion: In the MENA region, the majority of COPD subjects were overweight or obese, and comorbidities such as diabetes or cardiovascular diseases are likely to be associated with COPD when BMI is in the obese or morbidly obese ranges.

No MeSH data available.


Related in: MedlinePlus